Schedule 13D ownership disclosure
TURNSTONE BIOLOGICS CORP
Security class unavailable · CUSIP: 90042W100
Event date: 2023-07-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 13.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-23-000776
- Form type
- SC 13D
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- Jul 24, 2023
- Reporting period
- Jul 20, 2023
- Description
- Schedule 13D beneficial ownership